BioSpace News Archive

Fluidigm Corporation (NASDAQ:FLDM), announced today that The University of Michigan Protein Assembly Lab, a hub for collaborative and innovative research at the intersection of synthetic biology, protein engineering and personalized medicine,

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it has entered into a one-year agreement with Al Danah Medical Company (“Al Danah”) for distribution of the Obalon Navigation Balloon System in Qatar.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Royalty Pharma today announced that Ultragenyx has sold to Royalty Pharma for $320 million a royalty right due to Ultragenyx from Kyowa Kirin Co., Ltd for the net sales of Crysvita® (burosumab) in the European Union (EU), the United Kingdom (UK), and Switzerland.

ANI Pharmaceuticals, Inc. (“ANI”) (Nasdaq: ANIP) today announced the launch of Bretylium Tosylate Injection USP, 50 mg/mL

NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, today announced the appointment of Todd Verdoorn, PhD., as Vice President of Research and Development.

Mr. Brunel currently serves as Chief Executive Officer and Director at Biodesix, a company that develops and commercializes non-invasive blood-based molecular diagnostic tests for oncology.

Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced it has completed enrollment for its ongoing Phase 3 ultraVIOLET clinical trial for VT-1161

myTomorrows, a global health technology company, and Omeros Corporation (Nasdaq: OMER), an innovative biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics, today announced a collaboration.

Optimega LLC is changing the way people consume Omega-3 fatty acids. As an integral part of human development, Omega-3s are essential in building a healthy body, but the options for how to consume them have been fairly limited

Study Published in Psychopharmacology and Presented at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Shows Favorable Safety and Tolerability Profile of Regular Low Dose LSD